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The formation of myelinating Schwann cells (mSCs)
involves the remarkable biogenic process, which
rapidly generates the myelin sheath. Once formed,
the mSC transitions to a stable homeostatic state,
with loss of this stability associated with neuropa-
thies. The histone deacetylases histone deacetylase
1 (HDAC1) and HDAC2 are required for the myelina-
tion transcriptional program.Here,we showadistinct
role for HDAC3, in that, while dispensable for the for-
mation of mSCs, it is essential for the stability of the
myelin sheath once formed—with loss resulting in
progressive severe neuropathy in adulthood. This is
associated with the prior failure to downregulate the
biogenic program upon entering the homeostatic
state leading to hypertrophy and hypermyelination
of the mSCs, progressing to the development of
severe myelination defects. Our results highlight
distinct roles of HDAC1/2 and HDAC3 in controlling
the differentiation and homeostatic states of a cell
with broad implications for the understanding of this
important cell-state transition.
INTRODUCTION
Myelinating Schwann cells (mSCs) are critical for the function of
the peripheral nervous system (PNS) providing both a nurturing
function to axons and the periodic insulation essential for effi-
cient saltatory conduction (Salzer, 2015). The mSC is first spec-
ified before birth, during the axonal organization process known
as radial sorting, in which progenitor Schwann cells identify
axons larger than 1 mm in diameter associate in a 1:1 ratio and
in response to axonal signals exit the cell cycle and start to
express transcription factors specific to the myelinating cell
type (Jessen and Mirsky, 2005; Monk et al., 2015). Myelination
itself is initiated in the early post-natal period and is an extraordi-Cell Repo
This is an open access article undnary biogenic process involving a several thousand-fold expan-
sion in the specialized membrane that forms the myelin sheath
(Garbay et al., 2000). Once this process is complete, the mSC
transitions to the homeostatic state that can be maintained for
the lifespan of the animal. This requires the continued expression
of myelin genes but at the lower levels necessary for the mainte-
nance of the sheath (Decker et al., 2006; Salzer, 2015; Toyama
et al., 2013). The switch from a construction ‘‘biogenic’’ state
to amaintenance/homeostatic state, and the nature of the stabil-
ity of the homeostatic state, is likely to be important for many
non-dividing, long-lived cells in the body, but how these pro-
cesses are controlled remains poorly understood (Lloyd, 2013;
Roberts and Lloyd, 2012).
What is clear is that exquisite control of the transcriptional
regulation of the myelinating state is critical for the function
of the mSC (Nave et al., 2007; Pereira et al., 2012). In mice,
the myelination transcriptional program is initiated during
development in response to axonal signals and involves a tran-
scriptional feedforward network that ultimately leads to the
expression of the master transcriptional regulator of myelina-
tion, Krox-20, and the onset of myelination in the post-natal
period (Pereira et al., 2012; Stolt and Wegner, 2016; Topilko
et al., 1994). The Krox-20-dependent production of the myelin
sheath requires the rapid, extensive production of lipids and
myelin proteins yet the stability of this process is extremely
sensitive to the stoichiometry of its protein components (Ca-
margo et al., 2009; D’Antonio et al., 2013; Nave and Werner,
2014; Topilko et al., 1994). This has been most clearly demon-
strated by genetic neuropathies in which an additional copy of
a myelin gene is sufficient to induce a severe neuropathy (Nave
et al., 2007). Once the mSC is formed, the level of myelin gene
transcription drops to lower levels, but active myelin gene tran-
scription is still required in the adult, as shown by studies
showing that Krox-20 deletion in the adult resulted in demye-
lination (Decker et al., 2006). These studies demonstrate that
Krox-20-dependent transcription is required for both the differ-
entiation and maintenance of the myelinated state but implies
that additional regulatory processes must control the levels of
transcription.rts 25, 2755–2765, December 4, 2018 ª 2018 The Author(s). 2755
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Figure 1. HDAC3 Regulates Myelin Gene Transcription and Is Expressed in Adult Myelinating Schwann Cells
(A) Relative luciferase activity of the regulatory elements of the P0 gene (promoter plus enhancer; see STARMethods for further details) in the absence (control) or
presence (dbcAMP) of dbcAMP for 24 hr following the transfection of scrambled (Scr) or two independent siRNAs (siRNA1 and siRNA2) (n = 3, mean ± SEM).
(B) ChIP analysis to detect HDAC3 binding to the P0 promoter. SCs expressing a tamoxifen (TMX)-inducible Raf kinase construct (NSDRafER cells)were cultured
in the absence of presence of dbcAMP for 72 hr and then for a further 24 hr in the absence or presence (/+) of TMX to induce the dedifferentiation of the cells (n =
3, mean ± SEM).
(C) Relative endogeneous P0 mRNA levels following transfection of scrambled (Scr) or two independent siRNAs (siRNA1 and siRNA2) in the absence (control) or
presence (dbcAMP) of dbcAMP (n = 3, mean ± SEM).
(legend continued on next page)
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Histone deacetylases (HDACs) are a large family of proteins
that function as transcriptional regulators and control gene
expression mainly by modulating the acetylation levels of his-
toneswith resulting effects on chromatin compaction (Haberland
et al., 2009). HDACs were initially thought to act mainly as tran-
scriptional repressors and were found in large multiprotein com-
plexes with transcriptional co-repressors. However, numerous
more recent studies have shown that subsets of genes require
HDAC activity for their expression (Nott et al., 2016; Wang
et al., 2009; Zupkovitz et al., 2006). Furthermore, HDACs have
non-histone transcriptional targets and can exert some of their
functions independently of their enzymatic activity, suggestive
of more complex roles in regulating the multiprotein complexes
controlling transcription (Seto and Yoshida, 2014).
The class 1 HDACs, HDAC1, and HDAC2 and the associated
members of the NuRD complexes have been shown to play an
important role in regulating Schwann cell (SC) myelination
(Br€ugger et al., 2017; Hung et al., 2012; Jacob, 2017; Jacob
et al., 2011; Quintes et al., 2016; Wu et al., 2016). SC-specific
double knockout of HDAC1 and HDAC2 or knockout of NuRD
components leads to defects in SC myelination with the com-
plexes required both for the repression of progenitor genes
and the expression of the myelin gene program. Here, in a
non-biased screen, we identified HDAC3 as a regulator of myelin
gene expression. In contrast to HDAC1/2, we found that HDAC3
was not required for the development of the myelinating cell but
was instead critical for the entry into and the maintenance of the
homeostatic state. These findings provide insight into the mech-
anisms that can govern the transition into the homeostatic state
and have implications for the understanding of disorders such as
neuropathies and aging.
RESULTS
A Non-biased siRNA Screen Identifies HDAC3 as a
Regulator of Myelination
In order to identify transcriptional regulators of myelination, we
conducted a non-biased small interfering RNA (siRNA) screen
of chromatin regulators in primary SCs expressing a luciferase
reporter under the control of a well-characterized promoter-
enhancer region of the myelin protein zero (mpz) gene (P0) (LeB-
lanc et al., 2006). We identified HDAC3 as a potential regulator of
myelination and validation of the screen confirmed that HDAC3
was a positive regulator of the P0 transcriptional regulatory ele-
ments (Figures 1A and S1A). Chromatin immunoprecipitation
(ChIP) analysis confirmed that HDAC3 was found at the P0 pro-
moter in differentiated mSCs (Figure 1B). Moreover, knockdown
of HDAC3 in an in vitro differentiation assay confirmed that
HDAC3 is a positive regulator of myelin gene expression
(Figure 1C).
HDAC1 and HDAC2 have been shown to be expressed in SCs
during development and to be essential for SC myelination that(D) Representative confocal images of mouse sciatic nerve of postnatal P5, 6-wee
HDAC3 or HDAC2 (green) as indicated with SCs labeled for S100 (red). Note that w
cells (mSCs) (arrowheads), it is re-induced upon injury (arrowheads). Conversely,
it decreases upon injury in myelinating-derived SCs (arrowheads). Other cell typ
*p < 0.05, **p < 0.01, ***p < 0.001. See also Figure S1.takes place in the early post-natal period (Jacob, 2017; Jacob
et al., 2011). In adulthood, HDAC1/2 expression levels decrease
dramatically and the lower levels of HDAC2 appear to have a
distinct role in the adult in controlling paranodal and nodal sta-
bility (Br€ugger et al., 2015). However, HDAC1/2 levels increase
following injury as SCs return to a progenitor-like state consis-
tent with a role in the control of progenitor SC function (Jacob
et al., 2011). Notably, we found that HDAC3 had a very distinct
pattern of expression. Similarly to HDAC2, HDAC3 expression
was readily observed in the nuclei of mSCs at postnatal day 5;
however, in contrast to HDAC2, HDAC3 expression was
maintained in the adult in both mice and rats (Figures 1D and
S1B). Moreover, HDAC3 levels decreased following injury sug-
gesting distinct roles for HDAC1/2 and HDAC3 in regulating SC
behavior.
Loss of HDAC3 in Schwann Cells Results in a
Progressive Adult Neuropathy
In order to investigate the function of HDAC3 in SCs, we knocked
out HDAC3 specifically in SCs by crossingmice carrying a floxed
allele of HDAC3 (Montgomery et al., 2008) to mice expressing
Cre recombinase under the control of the P0 promoter
(P0:HDAC3fl/fl) (Feltri et al., 2002). This well-characterized pro-
moter drives the expression of Cre in SCs from around embry-
onic day 13.5, which is prior to SC driven axonal sorting or the
differentiation of SCs into either myelinating or non-myelinating
(Parrinello and Lloyd, 2009). Consistent with this, we found that
HDAC3 was efficiently (87.4% ± 4.6%) deleted from SCs during
development (Figures 2A and S2A–S2C) as determined by im-
munostaining, whereas HDAC3 levels remained unchanged in
other HDAC3-expressing cells, such as endothelial cells and
macrophages, within the nerve (Figure S2D).
Mutant mice developed normally and initially showed no
apparent abnormalities. However, upon reaching 2 months of
age, the mice began to develop motor deficits and with age
these deficiencies worsened to include severe weakness, limb
clasping, claw toe, and muscle wastage, especially in their rear
quarters (Figures 2B, 2C, S2E, and S2F; Video S1). These are
features that resemble Charcot-Marie-Tooth (CMT) syndromes
in humans (Vallat et al., 2013) and indicate that HDAC3 expres-
sion in SCs is required for proper nerve function.
In order to investigate the pathology of the sciatic nerves,
the nerves were analyzed at 36 weeks, when the phenotype
was severe. Toluidine-stained semi-thin sections showed
gross abnormalities of the nerves consistent with the behav-
ioral deficits. The defects varied from severe myelination ab-
normalities to regions in the distal portion of some nerves in
which nearly all axons appeared lost and the tissue appeared
fibrotic with abundant extracellular matrix (Figure S3A). Ultra-
thin electron microscopy (EM) images from the same mice
showed that loss of HDAC3 caused a variety of gross abnor-
malities in nearly all of the SC-axonal units (Figures 3A andk-old animals, and 6-week-old animals, 5 days following transection stained for
hereas HDAC2 expression in adulthood is at low levels in myelinating Schwann
nuclear HDAC3 expression is maintained in adult mSCs (arrowheads), whereas
es express high levels of HDAC3 after injury (arrows).
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Figure 2. Loss of HDAC3 in Schwann Cells
Results in Progressive Adult Neuropathy
(A) Immunofluorescence of representative trans-
verse sciatic nerve sections from control (HDAC3fl/fl)
miceatpostnatal day15ormutantmice (HDAC3DSC)
showing efficient loss of nuclear HDAC3 staining
(green) in S100-labeled SCs (red). Nuclei were
counterstained with Hoechst (blue). Arrows point to
mSCs and arrowheads to other cell types that also
express HDAC3.
(B) Imagesof6-month-oldHDAC3fl/fl andHDAC3DSC
animals showing hind limb clasping and muscle
wastage.
(C) Rotarod behavioral tests showing average
latency to fall of control HDAC3fl/fl and mutant
HDAC3DSC animals from 1 to 9 months after birth
(n = 4–19 mean ± SEM).
**p < 0.01, ***p < 0.001. See also Figure S2 and
Video S1.S3B and quantified in Figure 3B). Notably, myelin sheaths were
grossly affected and displayed dramatic myelin outfoldings
that have been associated with myelin dysregulation, usually
overproduction (Adlkofer et al., 1997; Bolis et al., 2005; Tersar
et al., 2007). A wide variety of defects were observed including
gross hypermyelination of individual axons, myelination of
more than one axon by an individual SC, and myelin outfold-
ings into the axon (Figures 3C and S3C). Interestingly, despite
these severe myelin abnormalities, the compaction and struc-
ture of the myelin appeared normal within the outfoldings (Fig-
ure S3B). Myelin degeneration was common and many axons
had lost their myelin sheath. This was accompanied by loss of
axons, suggesting that secondary to the SC myelination de-
fects there was also loss of neuronal fibers (Figures 3A, 3B,
and S3B).
mSCs Lacking HDAC3 Fail to Enter into the Adult
Homeostatic State
To determine the first manifestations of the phenotype, we
examined nerves from mice at earlier ages. At postnatal day
5, myelination is underway; however, it does not proceed syn-
chronously in that, at this time point, there is a mixture of2758 Cell Reports 25, 2755–2765, December 4, 2018axons that are myelinating, others that
remain unsorted within axonal bundles
and those that have been sorted into a
1:1 ratio with a SC but myelination has
not yet initiated (Figures 4A and S4A).
Consistent with the highly biogenic
state of the mSCs at this age, they
resemble ‘‘factories’’ with a large cyto-
plasm full of ER, Golgi, and mitochondria
(Figure S4B).
Interestingly, we found that, in contrast
to HDAC1/2 mutant mice, nerves appar-
ently developed normally in HDAC3
mutant mice with nerves from control
and mutant mice visibly indistinguishable
from each other (Figure 4A) with normalg-ratios indicating the mutant nerves develop normally with
SCs lacking HDAC3 (Figures 4A, 4B, and S4C). However, quan-
tification revealed a small decrease in the number of myelinated
axons per field and slightly larger numbers of unsorted axons
consistent with a minor delay in the myelination process; more-
over, a slight increase in axonal diameter was also observed
(Figures 4C–4E). This suggests that the mutant mice may
have a minor sorting defect that could affect the growth of
the axons, but the mildness of the phenotype makes this diffi-
cult to interpret. Interestingly at this stage, we observed a num-
ber of defects in the control animals with bundles of small
axons being myelinated by a single SC and abnormal outfold-
ings of myelin (Figures S4B) indicating that myelination is not
a perfect process during development. Overall, these results
indicate that while HDAC1/2 are required for myelination,
HDAC3 ablation in SCs has a minimal effect on these pro-
cesses, showing that HDAC3 is not required for SC myelination
or for the correct formation of Remak bundles.
By P15, myelination is more complete with some mSCs ap-
pearing to have finished the process. However, even at this
age, myelination has not been initiated in some mSCs, whereas,
in many others, the myelination process is still in progress
Figure 3. HDAC3 Loss in Schwann Cells Re-
sults in Gross Myelinating Abnormalities
(A) Representative EM images of transverse ultra-
thin sections of sciatic nerves from 9-month-old
HDAC3fl/fl and HDAC3DSC animals, when the
mutant animals exhibit profound neuropathies.
The two images from themutant animals represent
areas of less severe and severe myelination de-
fects.
(B) Quantification of myelination defects in 9-
month-old animals (n = 3 mean ± SEM).
(C) Selected images of myelination abnormalities
including myelin outfoldings (top left), focal hy-
permyelination (top right), the myelination of two
axons by a single SC (bottom left), and redundant
loop formation (bottom right).
*p < 0.05, ***p < 0.001. See also Figure S3.(Figures 5A and 5B). By this age, however, we were able to
clearly distinguish mutant from littermate control nerves in that
hypermyelination was observable in a small minority of SC:axo-
nal units (Figures 5A and 5B and quantified in Figure 5C). The
mildness of the phenotype was reflected by g-ratio analysis,
which showed that whereas the g-ratios were similar for the ma-
jority of axons in control and mutant animals, a few axons in the
mutant animals showed lower g-ratios consistent with hyper-
myelination (Figure 5D). Moreover, we performed 3D reconstruc-
tions of longitudinal EM sections of sciatic nerves to visualize de-
fects throughout the cells. This analysis confirmed the mildness
of the phenotype in that of five randomly selected mSCs from
control and mutant mice only one of each genotype showed ab-
normalities in the myelin sheath (Figure 5E; Video S2; data not
shown).
As the animals aged, we observed that the number of ab-
normalities progressively increased (Figures 6A–6C, S5A,
and S5B) with altered g-ratios observable by 4 weeks (Fig-
ure 6C). By 10 weeks, the vast majority of mSCs (>80%)
showed gross abnormalities consistent with the age at which
the first motor abnormalities were observed (Figures 2B, 6D,
and 6E). A notable abnormality was that many of the mSCs
displayed a massively enlarged cytoplasm and the nucleus
failed to appose to the myelin sheath in the majority of theCell Repocells (62.87% ± 9.97% SEM in mutant
mice at 6 weeks versus 0% in controls),
a characteristic position in normal
mature mSCs, which are highly polar-
ized (Figures 6D–6F). In addition, many
of these enlarged cells became filled
with comma-shaped myelin sheath out-
foldings and showed gross myelin
over-production. Consistent with this
abnormal nerve environment, an inflam-
matory response starting at 4 weeks
was observed with an increased number
of macrophages found within mutant
nerves (Figure S5C). By 6 months,
when the behavioral phenotype starts
to become more severe, a few axonsshowed complete demyelination (Figure S5D), which pro-
gressed to the severe axonal loss seen at 9 months (Figures
3A–3C and S3A–S3C).
Schwann Cells Lacking HDAC3 Remain in the Biogenic
Phase of Myelination
Between 2 and 4 weeks, as the myelination process passes its
peak, the high levels of myelin production required for the for-
mation of the myelin sheath drop to the levels needed to sus-
tain the myelin sheath during adulthood (Garbay et al., 2000).
This switch from the differentiation to the adult homeostatic
state is also associated with a characteristic morphological
change as the nucleus tightly apposes to the sheath and the
cytoplasm is restricted to a thin ribbon surrounding the sheath
(Figure 6D; Garbay et al., 2000; Nave and Werner, 2014). This
highly polarized structure is thought to be important for the
function of the mSC both to nurture the axon and to provide
the stable insulation required for efficient saltatory conduction
(Nave, 2010; Nave and Werner, 2014). This led us to hypothe-
size that, in HDAC3 mutant mice, this switch to the homeostat-
ic state was failing to take place and that the mSCs were
continuing to produce myelin at rates associated with the
differentiation stage. Consistent with this, we found that
HDAC3 mutant mice nerves at 6 weeks were transcribingrts 25, 2755–2765, December 4, 2018 2759
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Figure 4. Myelination Initiates Normally in
Schwann Cells Lacking HDAC3
(A) Representative colored EM images of sciatic
nerve sections from postnatal day 5 animals. Un-
sorted axons are shown in blue, single sorted
axons prior tomyelination are shown in yellow, and
sorted axons that have just initiated myelination
are indicated with a red asterisk.
(B) Graph shows the g-ratio as a function of axon
diameter of sciatic nerves from HDAC3fl/fl and
HDAC3DSC postnatal day 5 mice (n = 3 > 600
axons/genotype).
(C–E) Graphs show (C) quantification of the mye-
lination process as indicated, (D) the overall area of
unsorted axons, and (E) the axon diameters of
mSCs in the sciatic nerves of postnatal day 5
HDAC3fl/fl and HDAC3DSC mice (n = 3 mean ±
SEM).
*p < 0.05. See also Figure S4.much higher levels of myelin genes than control mice,
whereas, at early times during the peak of myelin production,
the levels were similar in the HDAC3 mutant and control
mice (Figures 7A and S6A). We did not observe increased
transcription of all of the myelin genes but think this is likely
due to the lack of synchrony of the process and the
inflammatory response, which would dilute the signal of the
myelin genes within the tissue. Consistent with this, we find
that, at 6 weeks, a number of the mSCs have been triggered
to dedifferentiate as measured by the expression of p75 (Fig-
ures S6B and S6C), as a result of the abnormal myelination
process.
Moreover, in line with mSCs that lack HDAC3 continuing to
remain highly biogenic, mutant mSCs retained the enlarged
cytoplasm only seen in control mSCs in their biogenic phase
(Figure 7B and quantified in Figure S6D). Moreover, the enlarged
cytoplasm was packed with ER, Golgi, and mitochondria and,
while larger, resembled normal mSCs in the ‘‘factory-like’’ phase
seen only during the post-natal differentiation period (Figures 7C
and 6C). Notably, the abnormally high level of myelin production
was not associated with increased signaling through the ERK or2760 Cell Reports 25, 2755–2765, December 4, 2018PI3-kinase pathways (Figure S6E). How-
ever, consistent with a highly biogenic
state in which the production of proteins
is maintained at an abnormally high rate,
an ER stress response was triggered in
mutant mice but was not detectable in
controls (Figure S6F). Notably, the ER-
stress response was consistent with the
enlarged ER visible in the EM sections at
this stage (Figure 7C).
These results indicate that HDAC3 re-
places HDAC1/2 at the transition from
the biogenic to the homeostatic state
and that loss of HDAC3 leads to a pro-
longed biogenic phase in mutant cells.
Consistent with this, in an in vitro differ-
entiation assay, we find that, similarly tothe process in vivo, the transcription rate of the P0 gene drops
as differentiation proceeds, (Figure 7D) and this is accompa-
nied by the loss of HDAC2 binding to the P0 enhancer (Figures
7E and S6G). Importantly, HDAC3 continues to bind at the
same time point (Figure 1C). Strikingly, in vivo analysis showed
that, whereas adult mSCs usually express HDAC2 and HDAC1
at very low levels, HDAC2 and HDAC1 levels remained high in
adult mSCs lacking HDAC3, consistent with the maintenance of
higher levels of myelin gene expression and the continuation of
the biogenic state (Figure 7F).
DISCUSSION
A mSC is a highly specialized polarized cell whose function is
critical for the normal function of the PNS. The myelin sheath is
produced rapidly in the early post-natal period in a remarkable
biogenic process. Once formed, the myelin sheath becomes a
stable structure, but the components of the sheath still turn
over, albeit slowly (Salzer, 2015). In a non-biased screen, we
identified HDAC3 as a positive regulator of myelin gene expres-
sion. The association of HDAC3 with the activation of gene
Figure 5. Myelination Defects Become
Apparent in Schwann Cells Lacking HDAC3
as Myelination Reaches Completion
(A and B) Representative low- (A) and high- (B)
magnification EM images of sciatic nerve sections
from postnatal day 15 control (HDAC3fl/fl) and
mutant (HDAC3DSC) mice. Note, while mostly
normal, a low percentage of axons show hyper-
myelination (white arrowhead). In addition, both
control and mutant animals show mSCs with an
enlarged cytoplasm (red *) indicating that myeli-
nation is not complete.
(C) Quantification of normal myelination and the
number of axons with myelination defects in
HDAC3fl/fl and HDAC3DSC mice (n = 3 mean ±
SEM).
(D) Graph shows the g-ratio as a function of axon
diameter of the sciatic nerves from postnatal day
15 HDAC3fl/fl and HDAC3DSC mice (n = 3 > 600
axons/genotype).
(E) Representative EM images of longitudinal ul-
trathin sections (left panel), higher magnification
(middle panel), and 3D reconstructions displaying
axons (white) and their myelin sheath (blue) (right
panel) of sciatic nerves from postnatal day 15
control (HDAC3fl/fl) and mutant (HDAC3DSC) mice
showing, in both cases, one mSC with myelin
outfoldings (top) and 2 normal mSCs (bottom).
*p < 0.05, **p < 0.01. See also Video S2.expression is consistent with recent studies, particularly those
involving oligodendrocyte lineage commitment and neuronal
function in which HDAC3 is not acting solely via its more estab-
lished role of decreasing histone acetylation but rather through
the modification and activation of transcriptional complexes
(Nott et al., 2016; Zhang et al., 2016). Remarkably, our analysis
of HDAC3 function in vivo has shown that HDAC3 has a specific
role in regulating the transition to a stable myelinating state,
whenmyelin genes need to remain expressed but at lower levels.Cell RepoFailure to transit to this state is associated
initially with hypertrophy, polarization ab-
normalities, and the overproduction of
myelin. As myelination is not a synchro-
nous process, the phenotype similarly
progressively develops as increasing
numbers of mSCs fail to enter the homeo-
static state. This then proceeds to severe
myelination dysregulation with resultant
stress responses, followed finally by
axonal loss and the development of se-
vere neuropathies. Importantly, these
phenotypes are reminiscent of known hu-
man neuropathies, which can be caused
by the overproduction of specific myelin
genes (Nave et al., 2007).
Our findings have similarities but are
clearly distinct from a recent study,
which also reported that HDAC3 loss
or inhibition can lead to hypermyelina-
tion (He et al., 2018). In contrast to ourfindings, however, they reported that HDAC3 was a negative
regulator of myelin gene expression and also proposed
HDAC3 inhibition as a mechanism to improve nerve regenera-
tion. Our results would contradict this suggestion. First, we
find that loss of HDAC3 does not result in premature myelina-
tion but rather normal myelination followed by an ‘‘overshoot’’
with a failure to enter the homeostatic state. This results in
grossly aberrant myelination and eventually a severe neurop-
athy, which is unlikely to be beneficial to the patient.rts 25, 2755–2765, December 4, 2018 2761
Figure 6. Schwann Cells Lacking HDAC3 Fail to Enter the Homeostatic State
(A) Quantification of myelination defects in the sciatic nerves of HDAC3fl/fl and HDAC3DSC mice at the indicated times (n = 3 mean ± SEM). Note that the graphs in
the top panel show that the density of normal mSCs in control animals decreases as the animal ages due to an increase in the overall size of the nerve with age.
(B) Graph shows the accumulation of myelin defects with age observable by normalizing to control levels (n = 3 mean ± SEM).
(C) Graphs show the g-ratio as a function of axon diameter of sciatic nerves from HDAC3fl/fl and HDAC3DSC 4-week-old mice (n = 3 > 600 axons/genotype) (left
panel) and the average g-ratio of postnatal day 5, day 15, and 4-week-old HDAC3fl/fl and HDAC3DSC mice (n = 3 mean ± SEM).
(D) Representative colored EM images of control (HDAC3fl/fl) and mutant (HDAC3DSC) mice. The cytoplasm is colored green with nuclei colored pink. Note the
nuclei remain unapposed to the axon in the mutant mice.
(E) Representative EM image of a longitudinal ultrathin sections of a sciatic nerve from 10-week-old mutant HDAC3DSC animals showing one normal (arrow) and
one abnormal (arrowhead) mSC displaying regions where the myelin sheath looks normal (green line) and some with outfoldings of myelin (red line).
(F) High-magnification EM image showing the enlarged cytoplasm and unapposed nuclei in the adult mutant mouse (10-week-old mouse).
*p < 0.05, **p < 0.01, ***p < 0.001. See also Figure S5.
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Figure 7. mSCs Lacking HDAC3 Remain in
the Biogenic State
(A) RT-qPCR analysis of key myelin genes and the
Krox-20 transcription factor at 6 weeks of age.
Primers that detect total mRNA or specific primer
pairs (-I) that detect only nascent pre-mRNA were
used. Prxn, periaxin (n = 4, mean ± SEM).
(B) S100 staining to detect the cytoplasm of SCs
shows the enlarged cytoplasm of the mSCs lack-
ing HDAC3. Nuclei are labeled with Hoechst (blue).
(C) Representative EM images showing that the
enlarged cytoplasm of mSCs lacking HDAC3
(HDAC3DSC) is packed with organelles such as
rough endoplasmic reticulum (RER) and mito-
chondria as seen in normal mSCS during their
most biogenic phase (day 5).
(D) RT-qPCR analysis of P0 mRNA (P0) and pre-
mRNA (P0-I) of SCs differentiated by the addition
of 1mM dbcAMP for the indicated times (n = 4
mean ± SEM).
(E) Graph shows ChIP analysis to detect HDAC2
bound to the P0 enhancer in SCs differentiated by
the addition of 1 mM dbcAMP for the indicated
times (n = 4 mean ± SEM).
(F) Representative immunofluorescence images
showing the expression of HDAC1 and HDAC2 in
transverse sections of sciatic nerves of 6-week-old
control (HDAC3fl/fl) and mutant (HDAC3DSC) mice.
Graph shows the average percentage of HDAC2+
mSCs in sciatic nerves from control (HDAC3fl/fl)
and mutant (HDAC3DSC) mice and in injured sciatic
nerves (mean ± SEM). Each dot represents an
individual animal.
*p < 0.05, **p < 0.01, ***p < 0.001. See also Fig-
ure S6.Moreover, following a transection injury, the major issue is not
the rate of remyelination but rather the speed of axonal re-
growth and a failure of axons to regrow back to their original
targets because of the disruption to the conduits following
the transection (Nguyen et al., 2002). It is thus highly unlikely
that a treatment that promotes hypermyelination would
improve this situation. Mechanistically, our findings are also
distinct. We found that while HDAC1 and 2 are associated
with the biogenic/developmental phase, HDAC3 controls the
entry to the adult homeostatic state. Consistent with this hy-
pothesis, we also find that, following injury, HDAC1/2 andCell RepoHDAC3 show different expression pat-
terns when remyelination is required, in
that HDAC1/2 expression is re-induced,
whereas HDAC3 nuclear expression
clearly decreases. This switch from the
biogenic to the homeostatic state is
associated with the replacement of
HDAC2 by HDAC3 on the transcriptional
regulatory elements of myelin genes
leading to lower levels of myelin gene
expression. Loss of HDAC3 results in a
failure to exit the biogenic phase and,
consistent with this, HDAC1/2 remains
expressed into adulthood with a result-ing failure to enter the homeostatic state and the development
of the hypermyelination phenotype.
The transition to a homeostatic state is a property of many
differentiated cells, particularly post-mitotic cells including neu-
rons, muscle cells, endothelial cells, and other types of glia.
When cells differentiate it usually involves the relatively rapid pro-
duction of material new and specific to this new cell state. How-
ever, once the transition is complete, many of these cells aim to
remain more or less the same throughout adulthood (Lloyd,
2013). This requires a stable, usually lower, level of transcription
of many of the same genes induced at high rates duringrts 25, 2755–2765, December 4, 2018 2763
differentiation. This state can change in a regenerative cell such
as a SCor a peripheral neuron, when upon injury the regenerative
process will involve the reinitiation of a more biogenic phase
(Cattin and Lloyd, 2016;Ma andWillis, 2015). In contrast, in path-
ological situations, abnormal overproduction by a cell is associ-
ated with hypertrophy (such as cardiac hypertrophy), degenera-
tive disorders such as CMT disease, developmental brain
disorders, and cancer (Crino, 2011; Lloyd, 2013). While the
events controlling switches in differentiation state have been
heavily studied, the less dramatic but critically important transi-
tion to a homeostatic state is still poorly understood. It is likely to
involve many mechanisms, but here we propose the differential
use of HDACs as one key mechanism governing the switch be-
tween the onset and the maintenance of the myelinating state.
Further studies will determine the full mechanistic implications
of this switch between HDAC2 and HDAC3. However, our find-
ings offer a unique insight into how these important transitions
can be achieved and are likely to have parallels in many similar
cell state transitions.STAR+METHODS
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Antibodies
Rabbit monoclonal anti-HDAC2 (clone Y461) IF: 1/400 Abcam Cat#ab32117 RRID:AB_732777
Mouse monoclonal anti-HDAC2 ChIP and WB: 1/1000 Abcam Cat#ab12169 RRID:AB_2118547
Rabbit polyclonal anti-HDAC3 ChIP, WB: 1/1000 and IF: 1/400 Abcam Cat#ab7030 RRID:AB_305708
Rabbit polyclonal anti-HDAC1 IF: 1/200 Abcam Cat#ab7028 RRID:AB_305705
Chicken polyclonal anti- 200kD neurofilament IF: 1/1000 Abcam Cat# ab4680 RRID: AB_30456
Rabbit polyclonal S100 IF: 1/1000 Dako Cat#Z0311 RRID:AB_10013383
Rat anti-mouse CD31 platelet endothelial cell adhesion molecule
(PECAM) IF: 1/50
BD Biosciences Cat# 553370 RRID: AB_394816
Mouse monoclonal S100 (clone SH-B1) IF: 1/500 Sigma-Aldrich Cat#S2532 RRID: AB_477499
Rabbit polyclonal anti-nerve growth factor (NGF-receptor)
p75 IF: 1/400
Millipore Cat# AB1554 RRID: AB_90760
Rat F4/80 monoclonal (clone Cl:A3-1) IF: 1/100 Bio-Rad Cat#MCA497 RRID:AB_2098196
Rabbit polyclonal ERK WB: 1/1000 Sigma-Aldrich Cat#M5670 RRID: AB_477216
Rabbit monoclonal P-Akt(Thr308) (clone C31E5E) WB: 1/1000 Cell Signaling Technology Cat#2965S RRID: AB_2255933
Rabbit monoclonal P-Akt(Ser473) (clone 193H12) WB: 1/1000 Cell Signaling Technology Cat#2336S RRID:AB_491022
Rabbit polyclonal P-ERK WB: 1/1000 Cell Signaling Technology Cat#4370S RRID: 2315112
Chicken polyclonal anti-myelin protein zero (P0) WB: 1/1000 Abcam Cat#ab39375 RRID:AB_881430
Rabbit polyclonal anti-GRP78 BiP WB: 1/1000 Abcam Cat# ab21685 RRID:AB_2119834
Goat anti-mouse Alexa Fluor 488 (IF) Thermo Fisher Scientific Cat#A11001 RRID:AB_2534069
Goat anti-rat Alexa Fluor 488 (IF) Thermo Fisher Scientific Cat#A11006 RRID:AB_2534074
Goat anti-Rabbit Alexa Fluor 594 (IF) Thermo Fisher Scientific Cat#A11012 RRID:AB_2534079
Goat anti-Mouse Alexa Fluor 647 (IF) Thermo Fisher Scientific Cat#21235 RRID:AB_141693
Goat anti-Chichen Alexa Fluor 647 (IF) Thermo Fisher Scientific Cat#A21449 RRID:AB_2535866
Sheep anti-mouse IgG, HRP GE Healthcare Cat#NA931 RRID:AB_772210
Donkey anti-rabbit IgG, HRP GE Healthcare Cat#NA934 RRID:AB_772206
Donkey anti-chicken IgG, HRP Sigma-Aldrich Cat#AP194P, RRID:AB_92682
Bacterial and Virus Strains
NSDRafER retrovirus Lloyd et al., 1997 N/A
Chemicals, Peptides, and Recombinant Proteins
4-hydroxytamoxifen Sigma-Aldrich Cat#H7904
dbcAMP Sigma-Aldrich Cat#DO627
insulin Sigma-Aldrich Cat#19278
hiperfect QIAGEN Cat#301707
attractene QIAGEN Cat#301005
Critical Commercial Assays
PureLink RNA Micro kit Thermo Fischer Scientific Cat#12183016
Dual Luciferase Reporter assay kit Promega Cat#E1910
Deposited Data
Raw and analyzed data This paper N/A
Experimental Models: Organisms/Strains
Crl:CD(SD) Rattus norvegicus Charles River Cat#734476, RRID:RGD_734476
C57BL/6N- Hdac3tm1a(EUCOMM)Wtsi Mus musculus EMMA Cat# WTSI:3856 RRID:IMSR_
WTSI:3856
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REAGENT or RESOURCE SOURCE IDENTIFIER
Tg(Mpz-cre)26Mes Mus musculus Feltri et al., 1999 N/A
Mouse: PLP-eGFP Mallon et al., 2002 N/A
Oligonucleotides
Primer for genotyping: HDAC3 Forward: ACCATGTGTCAAAGGAA
CAGTG
This paper N/A
Primer for genotyping: HDAC3 Reverse WT allele: GGTAACAACTG
CCATGGAAACA
This paper N/A
Primer for genotyping: HDAC3 Reverse targeted allele: GGGAAAGG
GTTCGAAGTTTCCTA
This paper N/A
Primer for genotyping: P0-Cre 1: CGGTCGATGCAACGAGTGATGAG This paper N/A
Primer for genotyping: P0-Cre 2: CCAGAGACGGAAATCCATCGCTC This paper N/A
Primers for RT-qPCR, see Table S1 This paper N/A
Primers for ChIP, see Table S2 This paper N/A
Si RNA targeting sequence: HDAC3 siRNA1: GAACUUCCCUAUAG
UGAAU
Dharmacon Cat#D-093064-01-0005
Si RNA targeting sequence: HDAC3 siRNA2: CGCCUGGCAUUGA
CUCAUA
Dharmacon Cat#D-093064-04-0005
Recombinant DNA
P0 promoter enhancer construct: pGL3-P0-Int-Pro LeBlanc et al., 2006 N/A
Renilla construct: pRL-CMV Promega Cat#E2261
Software and Algorithms
Fiji Schindelin et al., 2012 https://imagej.net/Fiji/Downloads
Amira Stalling et al., 2005 https://www.fei.com/software/
amira-for-cell-biology/
Prism GraphPad https://www.graphpad.com/
scientific-software/prism/CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Alison
Lloyd (alison.lloyd@ucl.ac.uk).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Generation of Schwann cell-specific mutant mice
HDAC3 mutant mice were generated using mice heterozygous for the Hdac3tm1a(EUCOMM)Wtsi allele carrying a neomycin (Neo)
resistance gene flanked by two FRT sites and two loxP sites that flank exon 3 from the European Mouse Mutant Archive (EMMA,
http://www.emma.org). Hdac3tm1a(EUCOMM)Wtsi /+ mice were crossed with FLP deleted mice (Farley et al., 2000) to remove
the Neo cassette (generous gift from Josef Kittler), leaving the Hdac3 exon 3 floxed by a pair of loxP site. Deletion of the floxed region
was achieved specifically in SCs by further crossing to P0-Cre mice (Feltri et al., 1999). Genotyping was performed by PCR of
genomic DNA using the following primers:
HDAC3 wt allele: ACCATGTGTCAAAGGAACAGTG and GGTAACAACTGCCATGGAAACA
HDAC3 targeted allele: ACCATGTGTCAAAGGAACAGTG
and GGGAAAGGGTTCGAAGTTTCCTA
P0-Cre 1: CGGTCGATGCAACGAGTGATGAGG
P0-Cre 2: CCAGAGACGGAAATCCATCGCTCG
Crosses with PLP-EGFP transgenicmice (Mallon et al., 2002) were performed for studies requiring GFP+ SCs in control (HDAC3fl/fl)
and mutant mice (HDAC3DSC).Cell Reports 25, 2755–2765.e1–e5, December 4, 2018 e2
Mouse husbandry
Mice were group-housed in a 12 hr light/dark cycle (light between 07:00 and 19:00) in a temperature-controlled room (21.1 ± 1.1C)
with free access to water and food. The ages of mice are indicated in the figure legends or methods. Sex was not determined for
neonatal pups. For analyses of older animals (> P15), both males and females were used.
Animal work was carried out in accordance to UK Home Office regulations.
Schwann cell culture and NSDRafER cell generation and culture
Rat primary SCs were cultured in DMEM- low glucose (1g/L) (Lonza) supplemented with 3% fetal bovine serum (FBS, Labtech.com)
1 mM forskolin (Abcam), 200nM L-Glutamine (GIBCO), Neuregulin, 100 mg/ml kanamycin and 800 mg/ml gentamycin (GIBCO) on poly-
L-lysine coated tissue culture plates and maintained at 37C and 10% CO2.
SCswere infected by co-cultivation at a 1:2 ratio with aDRafER expressing producer line that had been pre-treated withmitomycin
C (Lloyd et al., 1997). After two to three days, cultureswere transferred to selectivemedia containing 400 mg/mlG418 (GIBCO) and the
resulting drug resistant colonies pooled and expanded.
For the differentiation assays, NSDRafER cells were washed and cultured in serum-free SATO defined medium (Mitchell et al.,
2003). Cells were then induced to differentiate by the addition of 1mM dbcAMP (Sigma). To induce their dedifferentiation, DRafER
was activated by the addition of 100nM hydroxytamoxifen (Sigma) in ethanol (Harrisingh et al., 2004).
METHOD DETAILS
siRNA knockdown
siRNA HDAC3 knockdown was performed in NSDRafER cells using HiPerFect (QIAGEN). siRNA target sequences used at the indi-
cated concentrations were:
SiRNA1: GAACUUCCCUAUAGUGAAU at 5nM
SiRNA2: CGCCUGGCAUUGACUCAUA at 5nM
To test knockdown efficiency, cells were lysed in RIPA buffer (1% triton, 0.5% Na deoxycholate, 1mM EGTA, 50mM Tris pH 7.5,
protease and phosphatase inhibitors) and standard Western Blotting was performed.
Dual luciferase assay
To assess the effect of silencing HDAC3 on P0 enhancer-promoter activity, NSDRafER cells were cultured in 6-well plates until 80%
confluence was reached. Cells were transfected with 300ng pGL3-P0-Int-Pro luciferase vector (firefly), 5ng of Renilla and 5nM of
scrambled (QIAGEN), HDAC3 #1 or #2 siRNA (Dharmacon) with Attractene (Invitrogen). Complexes were added to the cells and incu-
bated for 2h at 37C.Cells were lysed 48h following transfection with a passive lysis buffer (Promega). Sampleswere processed using
the dual luciferase reporter assay system (Promega) according to the manufacturer’s instructions.
Sciatic nerve protein analysis
Immediately after dissection, sciatic nerves were snap-frozen in liquid nitrogen and stored at 80C until further processing. To
prepare protein lysates, nerves were crushed on dry ice, mixed with lysis buffer (25 mM Tris-HCl pH 7.4, 95 mM NaCl, 10 mM
EDTA, 2% SDS, protease and phosphatase inhibitors (Sigma)), boiled for 5 minutes, and spun for 15 minutes. The supernatant of
each sample was adjusted to the same concentration and mixed 1:4 with sample buffer (200 mM Tris-HCl pH6.8, 40% glycerol,
8% SDS, 20% b-mercaptoethanol, 0.4% bromophenol blue).
Western Blotting
Western blotting was performed using Hoefer Scientific Instrument apparatus and BioRad Western Blot electrophoresis system.
20-30 mg of protein was resolved using sodium dodecyl sulfate – polyacrylamide gel electrophoresis. Proteins were transferred
onto a nitrocellulose membrane (Millipore-Immobilon), which was then blocked in 5% milk-TBST for 1 hour at room temperature
(RT) and incubated overnight at 4C with the relevant primary antibody (see Key Resources Table). The following day, 3 washes in
TBS-T were performed before incubation with the appropriate HRP-conjugated secondary antibody (anti-mouse, GE Healthcare
NA931; antirabbit, GE Healthcare NA934; anti-chicken, Sigma-Aldrich AP194P) for 1 hour at RT at 1/5000. After 3 additional washes
in TBS-T, proteins of interest were detected with Pierce- ECL western blot substrate (Thermo Scientific) or Luminata Crescendo
Western HRP substrate (EMD-Millipore) and images acquired on the Imagequant LAS 4000.
qRT-PCR
Immediately after dissection, sciatic nerves were snap-frozen in liquid nitrogen and stored at 80C until further processing. Nerves
were crushed and homogenized on dry ice and then lysed in Trizol Reagent (Ambion). Nerves of three control or mutant animals were
pooled for P5 and P15 analysis; nerves of two animals were pooled when the analysis was performed at 6 weeks. Cells were directly
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instructions were followed with an additional step of DNase treatment (QIAGEN) to degrade the genomic DNA. 500ng-1 mg/ml of RNA
was then reverse-transcribed using Super-Script II Reverse Transcriptase (Invitrogen) and quantitative PCR (qPCR) was then per-
formed using the MESA Blue qPCR Kit (Eurogentec). 5 mL of template cDNA and 20 mL of MESA blue qPCRMasterMix Plus kit (Euro-
gentec) including 100nM forward and reverse primers (see sequences in Table S1) were used per reaction in a 96-well plate. Water
was used as a negative control. Relative expression values for each gene of interest were obtained after normalizing to b2m using the
primers described in Table S1.
Immunofluorescence
Sciatic nerves were dissected and fixed for a minimum of 4 hours in 4% PFA/PBS, cryoprotected in 30% sucrose/PBS overnight at
4C, incubated in 50%OCT/30% sucrose/PBS for 2 hours, embedded in OCT and finally frozen in liquid nitrogen. Cross cryosections
(12 mm) were cut using a cryostat (Leica), permeabilised in 0.3% triton/PBS for 30 minutes, washed and then blocked in 10% goat
serum (Sigma)/PBS for 1 hour at RT. Primary antibodies were diluted in 10%goat serum/PBS at the indicated concentration (see Key
Resources Table) and incubated overnight at 4C. After washing, the appropriate fluorescent secondary antibody (1/400, Alexa
fluor488, 594 from Thermo Fisher Scientific) was used with Hoechst to counterstain the nuclei for 1 hour at RT. Samples were
mounted in Fluoromount G (Southern Biotechnology). For HDAC1 immunostaining, nerve sections were first incubated for 5 minutes
in 70% EtOH, washed in PBS and then incubated with proteinase K (Roche) 40 mg/ml for 40 s. After washing, the above described
protocol of immunostaining was performed. For HDAC3 immunostaining, nerves were directly embedded in OCT and snap frozen in
liquid nitrogen. Cryosections were post-fixed in 4% PFA/PBS, permeabilised in 0.3% triton/PBS for 30 minutes and then blocked in
1/50 affiniPure Fab fragment donkey anti-mouse IgG (Jackson Immunoresearch) 10% goat serum/PBS overnight at 4C. After
washing, the above-described protocol of immunostaining was performed.
Nerve histology, histomorphometry, electron microscopy and g-ratio calculations
Sciatic nerves were dissected and fixed in 2% glutaraldehyde in 0.12M phosphate buffer pH 7.4 for up to 3 days at 4C. They were
then post-fixed in 2%osmium tetroxide overnight at 4Cand block stainedwith 2%uranyl acetate for 45minutes at 4C. Nerveswere
then dehydrated and embedded in epoxy resin. Semi-thin sections were cut using a diamond Histo knife (Diatome) at 0.1 mm, dried
and stained with 0.5% toluidine blue in 2%Borax at 75C for 30 s. Dried sections weremounted with DPX (Sigma) and representative
images were acquired using a wide-field microscope (Zeiss Axio Scope.A1). Ultrathin sections of 70nm were cut with a diamond
knife, collected onto formvar coated slot grids and stained with lead citrate. Representative images were acquired with a transmis-
sion electron microscope (T12 Tecnai Spirit, Thermo-Fischer) using a Morada camera and iTEM software (Olympus SIS).
Quantification of the number of axons, myelin defects, enlarged cytoplasm and unapposed nuclei was performed on at least
5 images per mouse, 3 mice per genotype. Nerves were blinded prior to analysis to avoid unconscious bias. Image fields of view
were 76.95x51.24 microns for mice aged 6 and 10 weeks and 50.49x33.62 microns for mice aged 4 weeks. For the graphs, the
same area (76.95x51.24 microns) was corrected for across ages. For 5 day old mice 30.45x20.28 micron image fields of view
were used to quantify the number of normal axons, axons with myelin defects and individual sorted axons (specified by a single
axon, separate from the axonal bundles and associated with a single SC) and the unsorted axons (specified by the total area of
an individual axonal bundle). We also used these images to quantify the size distribution of myelinated axons and the g-ratio.
Mean axon diameter (with and without myelin) was measured (10 fields, 3 mice per genotype) and binned based on their diameter.
g-ratios of individual axons as a measure of myelin thickness were determined by dividing the mean diameter of an axon without
myelin by the mean diameter of the same axon with myelin. All measurements were acquired using Photoshop to draw the axons
and their associated myelin sheath and Fiji software (Schindelin et al., 2012) to measure their mean diameter.
3D reconstruction of myelinated axons
More than 90 longitudinal, 70nm thick, serial sections were collected on formvar grids and the same region of axons serially imaged
manually, as above. Serial section images were aligned using TrakEM2 plugin (Cardona et al., 2010), segmented and rendered 3D
using Amira (Thermo Fischer).
ChIP
ChIP experiments were performed using a modified protocol based upon Malik et al., 2014 (Malik et al., 2014). Briefly, 12 million
(4x15cm plates) NSDRafER cells were used per condition for each experiment. Cells were washed once with PBS, and protein-
DNA complexes crosslinked by adding 1% PFA/PBS for 10 minutes at RT. Quenching of crosslinking was achieved by adding
125mM glycine for 5 minutes at RT. Cells were rinsed 3 times with cold PBS, then harvested in PBS. Following centrifugation at
2000 g for 10 minutes at 4C, cell pellets were snap frozen in liquid nitrogen and stored at 80C until required. Samples were
then resuspended and lysed in 1mL of buffer 1 (50mM HEPES-KOH, pH 7.5, 140mM NaCl, 1mM EDTA, pH 8.0, 10% glycerol,
0.5% NP-40, 0.25% Triton X-100 and complete protease inhibitor cocktail, PMSF, phosphatase inhibitors) per 6 million cells and
rotated for 10 minutes at 4C. Nuclei were pelleted by centrifugation at 1000 g for 10 minutes at 4C, then washed in 1ml of
buffer 2 (200mM NaCl, 1mM EDTA, pH 8.0, 0.5mM
EGTA, pH 8.0, 10mM Tris-HCl, pH 8.0, and complete protease inhibitor cocktail, PMSF, phosphatase inhibitors) per 6 million cells
and rotated for 10 minutes at 4C. Nuclei were again pelleted and resuspended in 400 mL buffer 3 (1mM EDTA, pH 8.0, 0.5mMEGTA,Cell Reports 25, 2755–2765.e1–e5, December 4, 2018 e4
pH 8.0, 10mM Tris-HCl, pH 8.0, and complete protease inhibitor cocktail, PMSF, phosphatase inhibitors) per 6 million cells. Sonicat-
ion was carried out using Bioruptor Sonication at high power setting. 30 pulses of 30 s each were delivered at this setting, then
insoluble materials were removed by centrifugation at 17000 g for 10 minutes at 4C. An additional 30 pulses of 30 s each were
then delivered, resulting in genomic DNA fragments with sizes ranging from 200bp to 1kb. Supernatant was collected and 2% of
the chromatin was reverse crosslinked (15 minutes at 95C in buffer 3 with 300mM NaCL), PCR purified (QIAGEN) and quantified
using Qubit (Thermo Fischer). Samples were then equalised in regards to protein amount and preclearing carried out with 50%
bead volume of protein A beads (GE Healthcare) prepared for ChIP (1.5g beads swelled O/N with PBS at 4C, washed 3 times
with TE buffer pH 8.0, resuspended in 20ml TE buffer pH 8.0 with 1.4mg salmon sperm DNA, 6mg BSA, 0.05% NaN3). Following
preclearing, supernatant was transferred to a new tube and supplemented so that it contains 165mM NaCL, 1% Triton X and
0.1% sodium deoxycholate. 10% of the sample was then saved as input. The remainder was incubated with 5 mg antibody
(2.5 ml) or IgG (12.5 ml) overnight at 4C (HDAC2, Abcam ab12169;mouse IgG, Santa Cruz sc-2025), rotating. The next day, samples
were incubated with 50 mL bead volume of protein A beads for 2 hours at 4C. Beads bound by immune complexes were pelleted by
centrifugation at 500 g for 1 minute at 4C, then washed twice with the following buffers: low-salt buffer (0.1% SDS, 1% Triton X-100,
2mM EDTA, 20mM Tris-HCl, pH 8.1, and 150mM NaCl), high-salt buffer (0.1% SDS, 1% Triton X-100, 2mM EDTA, 20mM Tris-HCl,
pH 8.1, and 500mMNaCl) and LiCl buffer (0.25M LiCl, 1% NP40, 1% sodium deoxycholate, 1mM EDTA and 10mM Tris, pH 8.1). For
each wash, beads were rotated for 10 minutes at 4C then spun at 500 g for 1 minute at 4C. Following the last wash, beads were
washed twice with TE buffer. Immunoprecipitated material was eluted by adding 100 mL of elution buffer (10mM Tris-HCl, pH 8.0,
1mM EDTA, pH 8.0, and 1% SDS) to each ChIP reaction, incubating at 65C 5 minutes with gentle mixing, then incubating at RT
with agitation for 10 minutes. Samples were spun at 10,000 g for 10 minutes at RT, supernatant saved, then beads eluted once
more. Elution buffer was added to each input so that input volume equals 200 ml. To ChIP samples and inputs, NaCl was added
to a final concentration of 300mM and crosslinking was reversed overnight at 65C. Samples were then purified using the QIAquick
PCR purification kit (QIAGEN), and DNA fragments were eluted in 40 mL of buffer EB/3 (elution buffer consisting of 10mMTris-HCl, pH
8.5; QIAGEN, diluted in water). Samples were assessed by gel or qPCR using primers for different genomic regions using primers
described in Table S2.
Behavioral Studies
Rotarod
Deterioration of motor function was tested using the accelerating Rotarod in mutant and control mice (n = 4-19/group) each month
from ages 1 to 9 months. Mice were subjected to three training trials in order to familiarise them with the procedure 24 hours prior to
each recording. Over a 5-minute period, Rotarod speed was gradually increased from 5 to 50 rpm and the time taken to fall recorded.
The mice were subject to three trials for each time point, and the average of these trials reported.
Grid Test
The grid test was performed as previously described (Lin et al., 2016). Mice were placed in the center of an elevated wire grid and
video recorded by a camera positioned underneath themesh for 3minutes. Foot faults were defined aswhen a hindpaw or forelimb of
themouse fell through the grid while walking. The cumulative timewith trapped limbs and the number of grid foot faults was recorded.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analysis was carried out using Prism statistical analysis software. All data are expressed as mean ± SEM unless otherwise
indicated. Data were analyzed using a one-way or two-way analysis of variance (ANOVA), followed by Tukey’s multiple comparisons
test, unpaired two-tailed Student’s t test or Mann-Withney test as appropriate. p values are indicated by asterisks as follows:
*p < 0.05, **p < 0.01, ***p < 0.001.e5 Cell Reports 25, 2755–2765.e1–e5, December 4, 2018
